|
1. HHS plans $200M cancer vaccine initiative: Wall Street Journal Full story
2. Clinicians divided amid growing demand for unproven autism drug Full story
3. Reviewer badge = complimentary access. 500+ speakers from UPMC, Cedars-Sinai and more at Becker's Health IT event: apply here.
4. Novo Nordisk failed to report adverse drug events: FDA Full story
5. GLP-1 receptor agonists tied to lower SUD risk: Study Full story
6. Your app portfolio may be your biggest unmanaged risk. Learn why: here.
7. Senate panel to probe FDA rare disease drug denials Full story
8. 3 updates on potential GLP-1 uses, risks Full story
Becker's Learning Opportunities
9. How 3 leading systems coordinate care for a complex, recurring heart condition here.
10. AHA shares how to launch + sustain a telehealth stroke program here.
11. Find treatment considerations for inflammatory heart disease from a cardiovascular specialist here.
12. Interested in more? See Becker’s full lineup of
webinars
and
whitepapers.
Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.
|
.png)
